Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) - A randomized, double-blind, placebo-controlled, parallel group,multi-center, phase II trial - RELIEF

Trial Profile

Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) - A randomized, double-blind, placebo-controlled, parallel group,multi-center, phase II trial - RELIEF

Recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Pirfenidone (Primary)
  • Indications Pulmonary fibrosis; Respiration disorders
  • Focus Therapeutic Use
  • Acronyms RELIEF
  • Most Recent Events

    • 15 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top